Minimize risks to avoid alarming the patient and compromising adherence.

Explain that clozapine carries risks including agranulocytosis (which requires regular blood monitoring through the REMS program), metabolic syndrome, myocarditis, seizures at higher doses, and significant sedation — while also explaining that clozapine is the most effective medication for treatment-resistant schizophrenia and that the monitoring protocol exists to detect problems early.

Refer the patient to the pharmacy for medication counseling rather than discussing risks directly.

Provide a printed medication guide and consider the consent complete.